Literature DB >> 24385287

Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation.

Judith Stift1, Hideo A Baba, Elisabeth Huber, Birgit Federmann, Hans-Peter Fischer, Annette Schmitt-Graeff, Herrad Baurmann, Wolfgang Bethge, Peter Schirmacher, Fritz Wrba, Hildegard Greinix, Falko Fend, Rainer Schwerdtfeger, Howard M Shulman, Daniel Wolff, Thomas Longerich.   

Abstract

After allogeneic hematopoietic cell transplantation (alloHCT) liver biopsy is performed for enigmatic liver disorders when noninvasive diagnostic steps have failed in establishing a definitive diagnosis. This document provides an updated consensus on the prerequisites for proper evaluation of liver biopsies in alloHCT patients and the histological diagnostic criteria for liver graft-versus-host disease (GvHD). The Working Group's recommendations for the histological diagnosis of liver GvHD were derived from the peer-reviewed literature and from the consensus diagnosis of a total of 30 coded liver biopsies. Acceptance of the recommendations was tested by a survey distributed to all HCT centers in Austria, Germany and Switzerland. Consensus was achieved for biopsy indications, methods of sample acquisition and processing, reporting and interpretation of biopsy findings. As GvHD is variably treated and the treatment modalities have changed over time, the panel endorses the use of more frequent biopsies in clinical studies in order to improve the present challenging clinical and diagnostic situation.

Entities:  

Mesh:

Year:  2014        PMID: 24385287     DOI: 10.1007/s00428-013-1528-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.535


  43 in total

Review 1.  Hepatobiliary complications of hematopoietic cell transplantation, 40 years on.

Authors:  George B McDonald
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

Review 2.  A systematic review of the quality of liver biopsy specimens.

Authors:  Evangelos Cholongitas; Marco Senzolo; Richard Standish; Laura Marelli; Alberto Quaglia; David Patch; Amar P Dhillon; Andrew Kenneth Burroughs
Journal:  Am J Clin Pathol       Date:  2006-05       Impact factor: 2.493

3.  Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation.

Authors:  N Fujii; K Takenaka; K Shinagawa; K Ikeda; Y Maeda; K Sunami; Y Hiramatsu; K Matsuo; F Ishimaru; K Niiya; T Yoshino; N Hirabayashi; M Harada
Journal:  Bone Marrow Transplant       Date:  2001-05       Impact factor: 5.483

4.  Histologic features of the liver biopsy predict the clinical outcome for patients with graft-versus-host disease of the liver.

Authors:  Rafael F Duarte; Julio Delgado; Bronwen E Shaw; David J Wrench; Mark Ethell; David Patch; Amar P Dhillon; Stephen Mackinnon; Mike N Potter; Alberto F Quaglia
Journal:  Biol Blood Marrow Transplant       Date:  2005-10       Impact factor: 5.742

Review 5.  A systematic approach to hepatic complications in hematopoietic stem cell transplantation.

Authors:  Sally Arai; Linda A Lee; Georgia B Vogelsang
Journal:  J Hematother Stem Cell Res       Date:  2002-04

6.  Analysis of the reversibility of chronic liver allograft rejection implications for a staging schema.

Authors:  K Blakolmer; E C Seaberg; K Batts; L Ferrell; R Markin; R Wiesner; K Detre; A Demetris
Journal:  Am J Surg Pathol       Date:  1999-11       Impact factor: 6.394

7.  Frequent expression of C4d in hepatic graft-versus-host disease: potential clue for diagnosis and distinguishing acute and chronic form.

Authors:  Sharif A Ali; Veena Shah; Rick McKinnon; Meredith Van Harn; Nalini Janakiraman
Journal:  Transpl Immunol       Date:  2010-03-15       Impact factor: 1.708

8.  Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation.

Authors:  Marco Mielcarek; Paul J Martin; Wendy Leisenring; Mary E D Flowers; David G Maloney; Brenda M Sandmaier; Michael B Maris; Rainer Storb
Journal:  Blood       Date:  2003-03-27       Impact factor: 22.113

9.  Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers.

Authors:  Daniel Wolff; Francis Ayuk; Ahmet Elmaagacli; Hartmut Bertz; Anita Lawitschka; Michael Schleuning; Ralf-Georg Meyer; Armin Gerbitz; Inken Hilgendorf; Gerhard C Hildebrandt; Matthias Edinger; Stephan Klein; Jörg Halter; Sabine Mousset; Ernst Holler; Hildegard T Greinix
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-29       Impact factor: 5.742

10.  Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation.

Authors:  S Y Ma; W Y Au; A K W Lie; I O L Ng; A Y H Leung; E W Tse; R H Liang; G K Lau; Y L Kwong
Journal:  Bone Marrow Transplant       Date:  2004-07       Impact factor: 5.483

View more
  9 in total

1.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Authors:  Howard M Shulman; Diana M Cardona; Joel K Greenson; Sangeeta Hingorani; Thomas Horn; Elisabeth Huber; Andreas Kreft; Thomas Longerich; Thomas Morton; David Myerson; Victor G Prieto; Avi Rosenberg; Nathaniel Treister; Kay Washington; Mirjana Ziemer; Steven Z Pavletic; Stephanie J Lee; Mary E D Flowers; Kirk R Schultz; Madan Jagasia; Paul J Martin; Georgia B Vogelsang; David E Kleiner
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-29       Impact factor: 5.742

Review 2.  Drug-induced Liver Injury: The Hepatic Pathologist's Approach.

Authors:  David E Kleiner
Journal:  Gastroenterol Clin North Am       Date:  2017-06       Impact factor: 3.806

3.  Biomarkers in chronic graft-versus-host disease: quo vadis?

Authors:  D Wolff; H Greinix; S J Lee; T Gooley; S Paczesny; S Pavletic; F Hakim; F Malard; M Jagasia; A Lawitschka; J A Hansen; D Pulanic; E Holler; A Dickinson; E Weissinger; M Edinger; S Sarantopoulos; K R Schultz
Journal:  Bone Marrow Transplant       Date:  2018-01-24       Impact factor: 5.483

4.  Consensus diagnostic histopathological criteria for acute gastrointestinal graft versus host disease improve interobserver reproducibility.

Authors:  Andreas Kreft; Anja Mottok; Ildiko Mesteri; Diana M Cardona; Anne Janin; Anja A Kühl; Mindaugas Andrulis; Andrea Brunner; Howard M Shulman; Giovanni Negri; Alexandar Tzankov; Elisabeth Huber
Journal:  Virchows Arch       Date:  2015-07-12       Impact factor: 4.064

5.  Risk factors and prognosis of hepatic acute GvHD after allogeneic hematopoietic cell transplantation.

Authors:  Y Arai; J Kanda; H Nakasone; T Kondo; N Uchida; T Fukuda; K Ohashi; K Kaida; K Iwato; T Eto; Y Kanda; H Nakamae; T Nagamura-Inoue; Y Morishima; M Hirokawa; Y Atsuta; M Murata
Journal:  Bone Marrow Transplant       Date:  2015-09-14       Impact factor: 5.483

Review 6.  Diagnosis and differential diagnosis of hepatic graft versus host disease (GVHD).

Authors:  Karen E Matsukuma; Dongguang Wei; Kai Sun; Rajendra Ramsamooj; Mingyi Chen
Journal:  J Gastrointest Oncol       Date:  2016-04

7.  Development of a novel histologic diagnostic algorithm for hepatic graft-versus-host disease.

Authors:  Ashley E Stueck; Thomas D Schiano; M Isabel Fiel
Journal:  Mod Pathol       Date:  2017-12-01       Impact factor: 7.842

8.  EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.

Authors:  Helene M Schoemans; Stephanie J Lee; James L Ferrara; Daniel Wolff; John E Levine; Kirk R Schultz; Bronwen E Shaw; Mary E Flowers; Tapani Ruutu; Hildegard Greinix; Ernst Holler; Grzegorz Basak; Rafael F Duarte; Steven Z Pavletic
Journal:  Bone Marrow Transplant       Date:  2018-06-05       Impact factor: 5.483

Review 9.  Steroid-refractory chronic graft-versus-host disease: treatment options and patient management.

Authors:  Daniel Wolff; Giancarlo Fatobene; Vanderson Rocha; Nicolaus Kröger; Mary E Flowers
Journal:  Bone Marrow Transplant       Date:  2021-07-03       Impact factor: 5.483

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.